What To Expect:

Check out our exclusive speaker interview with Thierry Bordet, Chief Scientific & Operating Officer at PulseSight Therapeutics, where he discuss the current most pressing dry AMD challenges and the benefits on having a industry-specific meeting for the dry AMD community.